104 related articles for article (PubMed ID: 14751897)
1. Indirect comparisons: a novel approach to assessing the effect of anti-HIV drugs.
Lundgren JD; Phillips AN
BMJ; 2004 Jan; 328(7434):253. PubMed ID: 14751897
[No Abstract] [Full Text] [Related]
2. Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trials.
Yazdanpanah Y; Sissoko D; Egger M; Mouton Y; Zwahlen M; Chêne G
BMJ; 2004 Jan; 328(7434):249. PubMed ID: 14742351
[TBL] [Abstract][Full Text] [Related]
3. What's new in the fight against AIDS.
Godwin C
RN; 2004 Apr; 67(4):46-52; quiz 53. PubMed ID: 15132046
[No Abstract] [Full Text] [Related]
4. Update on antiretroviral therapy.
Hicks CB
Radiol Clin North Am; 1997 Sep; 35(5):995-1005. PubMed ID: 9298086
[TBL] [Abstract][Full Text] [Related]
5. HIV-1. Viral assembly inhibitors on the horizon.
Brazil M
Nat Rev Drug Discov; 2005 Sep; 4(9):716-7. PubMed ID: 16211702
[No Abstract] [Full Text] [Related]
6. Effects of nucleoside reverse transcriptase inhibitor backbone on the efficacy of first-line boosted highly active antiretroviral therapy based on protease inhibitors: meta-regression analysis of 12 clinical trials in 5168 patients.
Hill A; Sawyer W
HIV Med; 2009 Oct; 10(9):527-35. PubMed ID: 19785663
[TBL] [Abstract][Full Text] [Related]
7. Can responses to antiretroviral therapy be improved by therapeutic drug monitoring?
Haas DW
Clin Infect Dis; 2006 Apr; 42(8):1197-9. PubMed ID: 16575742
[No Abstract] [Full Text] [Related]
8. Antiretroviral therapy in the treatment-experienced patient.
Gallant JE
AIDS Read; 1999 Jul; 9(4):284-91. PubMed ID: 12737118
[TBL] [Abstract][Full Text] [Related]
9. A clinically dangerous flaw in reporting statistical significance.
Campillo C; Puigventos F; Riera M
Clin Infect Dis; 2006 Apr; 42(8):1205-6; author repy 1206-7. PubMed ID: 16575745
[No Abstract] [Full Text] [Related]
10. [Current AIDS drugs].
Praxis (Bern 1994); 1997 Feb; 86(9):364-5. PubMed ID: 9157508
[No Abstract] [Full Text] [Related]
11. [HIV-1 therapy in the Netherlands; virological and immunological response to antiretroviral therapy].
Jambroes M; Weverling GJ; Reiss P; Danner SA; Jurriaans S; ten Veen JH; van der Ende ME; Schutten M; Schneider MM; Schuurman R; Mulder JW; Kroes AC; Lange JM; de Wolf F;
Ned Tijdschr Geneeskd; 2001 Aug; 145(33):1591-7. PubMed ID: 11534377
[TBL] [Abstract][Full Text] [Related]
12. Antiretroviral drug treatment for HIV/AIDS.
Goldschmidt RH; Moy A
Am Fam Physician; 1996 Aug; 54(2):574-80, 587-8. PubMed ID: 8701838
[TBL] [Abstract][Full Text] [Related]
13. [HIV infection, acquired immunodeficiency syndrome (AIDS)].
Izumo S
Nihon Rinsho; 2004 Jan; 62 Suppl():219-23. PubMed ID: 15011353
[No Abstract] [Full Text] [Related]
14. Tenofovir: new indication. For first-line antiretroviral therapy: wait and see.
Prescrire Int; 2004 Oct; 13(73):180-2. PubMed ID: 15499699
[TBL] [Abstract][Full Text] [Related]
15. Initiation of antiretroviral therapy: implications of recent findings.
Saag MS
Top HIV Med; 2004; 12(3):83-8. PubMed ID: 15310939
[TBL] [Abstract][Full Text] [Related]
16. Therapy of HIV infection.
Chang YC; Tyring SK
Dermatol Ther; 2004; 17(6):449-64. PubMed ID: 15571495
[TBL] [Abstract][Full Text] [Related]
17. Impact of mutations conferring reduced susceptibility to lamivudine on the response to antiretroviral therapy.
Perno CF; Cozzi-Lepri A; Balotta C; Forbici F; Violin M; Bertoli A; Facchi G; Pezzotti P; Angarano G; Arici C; Narciso P; Orani A; Raise E; Scalzini A; Poggio A; Ippolito G; Moroni M; Monforte AD;
Antivir Ther; 2001 Sep; 6(3):195-8. PubMed ID: 11808755
[No Abstract] [Full Text] [Related]
18. The development of anti-HIV-1 drugs.
Lu XF; Chen ZW
Yao Xue Xue Bao; 2010 Feb; 45(2):165-76. PubMed ID: 21348415
[TBL] [Abstract][Full Text] [Related]
19. Inadvertent non-nucleoside reverse transcriptase inhibitor (NNRTI)-based antiretroviral therapy in dual HIV-1/2 and HIV-2 seropositive West Africans: a retrospective study.
Sarfo FS; Bibby DF; Schwab U; Appiah LT; Clark DA; Collini P; Phillips R; Green I; Dittmar MT; Chadwick DR
J Antimicrob Chemother; 2009 Sep; 64(3):667-9. PubMed ID: 19549668
[No Abstract] [Full Text] [Related]
20. Antiretrovirals, part 1: overview, history, and focus on protease inhibitors.
Wynn GH; Zapor MJ; Smith BH; Wortmann G; Oesterheld JR; Armstrong SC; Cozza KL
Psychosomatics; 2004; 45(3):262-70. PubMed ID: 15123854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
